1Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab,2002,87( 3 ) :978-982.
2Frankenfield DC, Omert LA, Badellino MM, et al. Correlation between measured energy expenditure and clinically obtained variables in trauma and sepsis patients. JPEN J Parenter Enteral Nutr, 1994, 18:398-403.
3Kuroda M, Honnor RC, Cushman SW, et al. Regulation of insulinstimulated glucose trans port in the isolated ratadipocyte camp-in dependent effect soflipoly ticandantilipoly ticagents. J Biol Chem, 1987,262:215.
6Oksanen T, Skrifvars MB, Varpula T, et al. Strict versus moderate glucose control after resuscitation from ventricular fibrillation. Intensive Care Med,2007 ,33 :2093-2100.
7Losert H, Sterz F, Roine RO, et al. Strict normoglycaemic blood glucose levels in the therapeutic management of patients within 12 h after cardiac arrest might not be necessary. Resuscitation, 2008,76: 214-220.
8Genuth SM. The endocrine system. In:Berne RM, Levy MN eds. Physiology. St. Louis :C. V. Mosby, 1998,819-874.
4American College of Chest Physician/Society of Critical Care Medicine Consensus: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992,20(6):864 - 874.
5Van den Berghe G, Wouters PJ, Weekers F, et al. Intensive insulin therapy in the critically ill patients[J] .N Engl J Med, 2001,345( 19):1359- 1367.
7Johan Groeneveld AB, Beishuizen A, Visser FC.Insulin: a wonder drug in the criticallyill[J]? Crit Care, 2002,6(2): 102- 105.
8Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control[J]. Crit Care Med, 2003,31:359- 366.
